In this report we find that many genes regulated by the ERβ variants are direct targets of either HIF-1α or HIF-2α indicating a potentiation of hypoxic signaling, which has previously been shown to affect breast cancer aggressiveness [4–7, 10, 12, 13, 16, 17, 20]. This evidence concerns the gene ESR2 and breast carcinoma.